$656 Million is the total value of SECTOR GAMMA AS's 28 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 30.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ABT | Sell | ABBOTT LABS | $67,860,000 | -9.2% | 1,271,742 | -17.3% | 10.34% | -4.8% |
| LLY | Buy | LILLY ELI & CO | $61,550,000 | +57.4% | 719,546 | +51.4% | 9.38% | +65.0% |
| BAX | Sell | BAXTER INTL INC | $58,617,000 | -9.5% | 934,133 | -12.7% | 8.93% | -5.2% |
| BSX | Buy | BOSTON SCIENTIFIC CORP | $42,847,000 | +7.5% | 1,468,880 | +2.2% | 6.53% | +12.7% |
| PKI | Sell | PERKINELMER INC | $37,355,000 | -13.2% | 541,608 | -14.2% | 5.69% | -9.0% |
| ANTM | Buy | ANTHEM INC | $34,674,000 | +2.7% | 182,610 | +1.8% | 5.28% | +7.7% |
| BMY | Sell | BRISTOL MYERS SQUIBB CO | $29,295,000 | -40.9% | 459,606 | -48.3% | 4.46% | -38.0% |
| IRWD | Sell | IRONWOOD PHARMACEUTICALS INC | $28,780,000 | -16.8% | 1,825,002 | -0.4% | 4.39% | -12.8% |
| GILD | Sell | GILEAD SCIENCES INC | $27,198,000 | -29.9% | 335,690 | -38.8% | 4.15% | -26.5% |
| IART | Buy | INTEGRA LIFESCIENCES HLDGS C | $26,716,000 | -0.6% | 529,230 | +7.3% | 4.07% | +4.2% |
| BIIB | Buy | BIOGEN IDEC INC | $26,302,000 | +67.7% | 84,000 | +45.3% | 4.01% | +75.8% |
| AZN | New | ASTRAZENECA PLCsponsored adr | $25,094,000 | – | 740,671 | +100.0% | 3.82% | – |
| SHPG | Sell | SHIRE PLCsponsored adr | $24,833,000 | -27.7% | 162,156 | -22.0% | 3.78% | -24.2% |
| BIO | Sell | BIO RAD LABS INCcl a | $24,320,000 | -6.5% | 109,440 | -4.8% | 3.71% | -2.0% |
| PRGO | Sell | PERRIGO CO PLC | $23,655,000 | +6.9% | 279,440 | -4.7% | 3.60% | +12.0% |
| MCK | Buy | MCKESSON CORP | $18,295,000 | -4.2% | 119,100 | +2.6% | 2.79% | +0.4% |
| PDCO | Buy | PATTERSON COMPANIES INC | $15,318,000 | -15.5% | 396,332 | +2.6% | 2.34% | -11.4% |
| CLVS | New | CLOVIS ONCOLOGY INC | $12,203,000 | – | 148,092 | +100.0% | 1.86% | – |
| LH | Sell | LABORATORY CORP AMER HLDGS | $10,568,000 | -19.3% | 70,000 | -17.6% | 1.61% | -15.4% |
| NUVA | New | NUVASIVE INC | $10,149,000 | – | 183,000 | +100.0% | 1.55% | – |
| LXRX | Buy | LEXICON PHARMACEUTICALS INC | $9,063,000 | -11.5% | 737,453 | +18.4% | 1.38% | -7.3% |
| IPXL | Sell | IMPAX LABORATORIES INC | $8,572,000 | -9.7% | 422,261 | -28.3% | 1.31% | -5.2% |
| THC | Sell | TENET HEALTHCARE CORP | $8,464,000 | -23.9% | 515,180 | -10.4% | 1.29% | -20.2% |
| CI | Sell | CIGNA CORPORATION | $6,238,000 | -55.8% | 33,370 | -60.4% | 0.95% | -53.6% |
| MNTA | Sell | MOMENTA PHARMACEUTICALS INC | $5,921,000 | -42.1% | 320,055 | -47.1% | 0.90% | -39.4% |
| GSK | New | GLAXOSMITHKLINE PLCsponsored adr | $5,548,000 | – | 136,655 | +100.0% | 0.85% | – |
| OMI | OWENS & MINOR INC NEW | $5,136,000 | -9.3% | 175,874 | 0.0% | 0.78% | -4.9% | |
| RDUS | New | RADIUS HEALTH INC | $1,510,000 | – | 39,173 | +100.0% | 0.23% | – |
| ALXN | Exit | ALEXION PHARMACEUTICALS INC | $0 | – | -40,300 | -100.0% | -0.71% | – |
| LPNT | Exit | LIFEPOINT HEALTH INC | $0 | – | -149,714 | -100.0% | -1.46% | – |
| MASI | Exit | MASIMO CORP | $0 | – | -201,418 | -100.0% | -2.67% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-11-07
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BOSTON SCIENTIFIC CORP | 40 | Q1 2023 | 9.9% |
| BIO RAD LABS INC | 40 | Q1 2023 | 4.7% |
| BRISTOL-MYERS SQUIBB CO | 38 | Q3 2023 | 11.9% |
| BAXTER INTL INC | 34 | Q3 2023 | 12.7% |
| CARDINAL HEALTH INC | 34 | Q3 2023 | 8.1% |
| PERKINELMER INC | 33 | Q2 2021 | 6.3% |
| BIOGEN INC | 30 | Q3 2023 | 7.6% |
| ELEVANCE HEALTH INC | 30 | Q3 2023 | 5.6% |
| GILEAD SCIENCES INC | 29 | Q3 2023 | 14.0% |
| TENET HEALTHCARE CORP | 28 | Q3 2023 | 4.3% |
View SECTOR GAMMA AS's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-05 |
| 13F-HR | 2023-11-06 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-12 |
| 13F-HR/A | 2023-02-08 |
| 13F-HR | 2023-02-07 |
| 13F-HR | 2022-11-09 |
| 13F-HR | 2022-08-05 |
| 13F-HR | 2022-05-06 |
| 13F-HR | 2022-02-08 |
View SECTOR GAMMA AS's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.